Azacitidine (Fresenius Kabi USA, LLC)
Welcome to the PulseAid listing for the Azacitidine drug offered from Fresenius Kabi USA, LLC. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Fresenius Kabi USA, LLC |
| NON-PROPRIETARY NAME: | Azacitidine |
| SUBSTANCE NAME: | AZACITIDINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| ROUTE: | INTRAVENOUS; SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-03-16 |
| END MARKETING DATE: | 0000-00-00 |
Azacitidine HUMAN PRESCRIPTION DRUG Details:
| Item Description | Azacitidine from Fresenius Kabi USA, LLC |
| LABELER NAME: | Fresenius Kabi USA, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/30mL) |
| START MARKETING DATE: | 2017-03-16 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63323-771_3b594aba-e798-4105-b801-0b0d970747c1 |
| PRODUCT NDC: | 63323-771 |
| APPLICATION NUMBER: | ANDA207518 |
Other AZACITIDINE Pharmaceutical Manufacturers / Labelers:
